Scailyte

Basel, Switzerland

True precision medicine through single-cell science

$1.8M raised

Dec 2023

Series A

Top Investors

Verve VenturesSwisscom VenturesMassChallengeVenture KickInnosuisse

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Scailyte raised?

Scailyte has raised $1.8M in total funding. The most recent round was Series A. The last funding was announced in December 2023.

Who are Scailyte's investors?

Scailyte's investors include Verve Ventures, Swisscom Ventures, MassChallenge, Venture Kick, Innosuisse.

Where is Scailyte headquartered?

Scailyte is headquartered in Basel, Switzerland.

What does Scailyte do?

True precision medicine through single-cell science

What stage is Scailyte at?

Scailyte is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 4, 2023.

MLA

"Scailyte — Funding & Investors." VCBacked, December 4, 2023, https://www.vcbacked.co/company/scailyte. Accessed June 3, 2026.

APA

VCBacked. (2023). Scailyte — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/scailyte

Wikipedia (cite web)

{{cite web |title=Scailyte — Funding & Investors |url=https://www.vcbacked.co/company/scailyte |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 4, 2023.